Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

Search Results

22 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Results By Year timeline is not available.
Page 1
Guidelines for visualization and analysis of DC in tissues using multiparameter fluorescence microscopy imaging methods.
Bayerl F, Bejarano DA, Bertacchi G, Doffin AC, Gobbini E, Hubert M, Li L, Meiser P, Pedde AM, Posch W, Rupp L, Schlitzer A, Schmitz M, Schraml BU, Uderhardt S, Valladeau-Guilemond J, Wilflingseder D, Zaderer V, Böttcher JP. Bayerl F, et al. Among authors: valladeau guilemond j. Eur J Immunol. 2023 Nov;53(11):e2249923. doi: 10.1002/eji.202249923. Epub 2023 Jan 9. Eur J Immunol. 2023. PMID: 36623939
Unique CLR expression patterns on circulating and tumor-infiltrating DC subsets correlated with clinical outcome in melanoma patients.
Sosa Cuevas E, Valladeau-Guilemond J, Mouret S, Roubinet B, de Fraipont F, Landemarre L, Charles J, Bendriss-Vermare N, Chaperot L, Aspord C. Sosa Cuevas E, et al. Among authors: valladeau guilemond j. Front Immunol. 2022 Oct 24;13:1040600. doi: 10.3389/fimmu.2022.1040600. eCollection 2022. Front Immunol. 2022. PMID: 36353633 Free PMC article.
Diversification of circulating and tumor-infiltrating plasmacytoid DCs towards the P3 (CD80+ PDL1-)-pDC subset negatively correlated with clinical outcomes in melanoma patients.
Sosa Cuevas E, Bendriss-Vermare N, Mouret S, De Fraipont F, Charles J, Valladeau-Guilemond J, Chaperot L, Aspord C. Sosa Cuevas E, et al. Among authors: valladeau guilemond j. Clin Transl Immunology. 2022 May 3;11(5):e1382. doi: 10.1002/cti2.1382. eCollection 2022. Clin Transl Immunology. 2022. PMID: 35517992 Free PMC article.
Identification of shared tumor epitopes from endogenous retroviruses inducing high-avidity cytotoxic T cells for cancer immunotherapy.
Bonaventura P, Alcazer V, Mutez V, Tonon L, Martin J, Chuvin N, Michel E, Boulos RE, Estornes Y, Valladeau-Guilemond J, Viari A, Wang Q, Caux C, Depil S. Bonaventura P, et al. Among authors: valladeau guilemond j. Sci Adv. 2022 Jan 28;8(4):eabj3671. doi: 10.1126/sciadv.abj3671. Epub 2022 Jan 26. Sci Adv. 2022. PMID: 35080970 Free PMC article.
Type 1 conventional dendritic cells and interferons are required for spontaneous CD4+ and CD8+ T-cell protective responses to breast cancer.
Mattiuz R, Brousse C, Ambrosini M, Cancel JC, Bessou G, Mussard J, Sanlaville A, Caux C, Bendriss-Vermare N, Valladeau-Guilemond J, Dalod M, Crozat K. Mattiuz R, et al. Among authors: valladeau guilemond j. Clin Transl Immunology. 2021 Jul 14;10(7):e1305. doi: 10.1002/cti2.1305. eCollection 2021. Clin Transl Immunology. 2021. PMID: 34277006 Free PMC article.
Hepatitis B virus exploits C-type lectin receptors to hijack cDC1s, cDC2s and pDCs.
Ouaguia L, Dufeu-Duchesne T, Leroy V, Decaens T, Reiser JB, Sosa Cuevas E, Durantel D, Valladeau-Guilemond J, Bendriss-Vermare N, Chaperot L, Aspord C. Ouaguia L, et al. Among authors: valladeau guilemond j. Clin Transl Immunology. 2020 Dec 8;9(12):e1208. doi: 10.1002/cti2.1208. eCollection 2020. Clin Transl Immunology. 2020. PMID: 33312564 Free PMC article.
22 results